Back to search

Czechia· CZ-0233886

KALIUM SULFURICUM DHU

A v12 product containing kalii sulfas - dilutio homeopathica, registered in Czechia by Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG, Karlsruhe.

ATC V12

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedKALIUM SULFURICUM DHUATCV12REGISTER NO.CZ-0233886PACKS LISTED0CHECKEDSeptember 28, 2026

The record

At a glance

SÚKL (Czech Republic)
Active substance
KALII SULFAS - DILUTIO HOMEOPATHICA
Manufacturer
Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG, Karlsruhe
Country
Czechia (CZ)
ATC code
V12
ATC class
V12
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f11e2582-ef91-46a7-8ec6-f0b14b677d84
GET /v1/drugs/f11e2582-ef91-46a7-8ec6-f0b14b677d84?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "D5-D30",
  "pack_size": "1000",
  "substance": "KALII SULFAS - DILUTIO HOMEOPATHICA",
  "cz_kod_sukl": "0233886",
  "product_type": "HO",
  "substance_codes": "50179",
  "registration_state": "B",
  "registration_number": "93/274/92-A/C"
}

See everything about kalii sulfas - dilutio homeopathica.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.